ACADIA PHARMACEUTICALS INC (ACAD) — institutional ownership

375 funds reported holding ACADIA PHARMACEUTICALS INC in their latest 13F filings, worth $4.73B in total (CUSIP 004225108).

Largest holders

1. BAKER BROS. ADVISORS LP — $1.09B
2. BlackRock, Inc. (BLK) — $570M
3. VANGUARD GROUP INC — $405M
4. STATE STREET CORP (STT, STT-PG) — $230M
5. VANGUARD PORTFOLIO MANAGEMENT LLC — $224M
6. RTW INVESTMENTS, LP — $181M
7. VANGUARD CAPITAL MANAGEMENT LLC — $146M
8. DIMENSIONAL FUND ADVISORS LP — $93.5M
9. GEODE CAPITAL MANAGEMENT, LLC — $85.0M
10. Palo Alto Investors LP — $72.5M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)
• Izzy Englander portfolio (Millennium Management)
• Ray Dalio portfolio (Bridgewater Associates)

Insider buying and selling at ACADIA PHARMACEUTICALS INC

Who owns the most ACAD stock?

The largest institutional holders in the latest 13F filings are BAKER BROS. ADVISORS LP ($1.09B), BlackRock, Inc. (BLK) ($570M), VANGUARD GROUP INC ($405M).

How many funds own ACAD?

375 funds reported holding it, worth $4.73B in total.